A Hidden Crisis: The Impact of Opportunistic Infections

The World Health Organization defines AHD by a CD4 count below 200 cells/mm³ or WHO Stage 3 or 4 illness. This includes people who have never received antiretroviral therapy (ART) and those returning to care after interrupted treatment. All children younger than five years of age are considered to have advanced HIV disease. 

People with AHD are at high risk of death. Even after starting treatment, this risk increases with decreasing CD4 cell count. The most common causes of severe illness and death are tuberculosis, severe bacterial infections and cryptococcal meningitis.

Advanced HIV disease (AHD) remains one of the greatest threats to ending AIDS for good. It affects millions of people who either begin treatment late, face treatment failure, or return to care after an interruption—each case a reminder of the urgent need to strengthen every step of the HIV response.

People living with advanced HIV disease make up nearly one-third of all individuals in active care. They are at higher risk of severe opportunistic infections like tuberculosis, bacterial infections, and cryptococcal meningitis, which can quickly become fatal without timely diagnosis and treatment.

Yet, despite the clear burden, national strategies and funding priorities often fail to address the complexity of AHD. Without dedicated resources for diagnosis, treatment, and long-term retention in care, preventable deaths continue—especially across sub-Saharan Africa.

EGPAF is leading efforts to close these deadly gaps

Patient-centered, differentiated models of care improve how individuals are screened, diagnosed, treated, and supported. We are working to expand access to the full WHO-recommended package of care for people with advanced HIV disease, including:

CD4 testing

at entry or re-entry into care to identify those at highest risk

Point-of-care screening tools

for TB and cryptococcal infection

Access to new and lifesaving medicines

to prevent and treat the leading causes of HIV-related mortality

By combining innovation, advocacy, and partnership with ministries of health, EGPAF is helping ensure that no person living with HIV is left behind—no matter when or how they enter care.